Trials
Search / Trial NCT06439719

Plaque Composition in T2DM With and Without Microvascular Complications

Launched by FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS · May 28, 2024

Apply for Trial

Trial Information

Current as of March 13, 2025

Not yet recruiting

Keywords

ClinConnect Summary

Subjects with T2DM who performed CT coronary imaging, as per clinical routine practice.

They will be, therefore, divided into two groups:

* Group A: subjects with T2DM with at least one DMC, as defined:

• Retinopathy, defined as any diabetes related eye disease (macular oedema, severe non proliferative diabetic retinopathy, proliferative diabetic retinopathy) or previous history of retinal photocoagulation therapy and/or intravitreal injections of anti- vascular endothelial growth factor (VEGF) agents.
* Neuropathy, including any diabetes-related neurological complication (diabetic p...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • 1. Informed consent signed before any activity related to the study
  • • 2. Age 40 - 70 years, both sexes
  • • 3. Diagnosis of T2DM ≥5 years
  • • 4. CT coronary imaging performed in 60 days before enrollment
  • Exclusion Criteria:
  • • 1. Previous diagnosis of type 1 diabetes, late autoimmune diabetes of the adults (LADA), diabetes secondary to pancreatitis
  • • 2. Malignant disease
  • • 3. Acute/chronic inflammatory disease
  • • 4. Severe obesity

About Fondazione Policlinico Universitario Agostino Gemelli Irccs

Fondazione Policlinico Universitario Agostino Gemelli IRCCS is a leading research and healthcare institution based in Rome, Italy, renowned for its commitment to advancing medical science and improving patient care. As a prominent academic medical center affiliated with the Catholic University of the Sacred Heart, it integrates clinical practice, education, and research, fostering innovation in various fields of medicine. The foundation conducts a wide range of clinical trials aimed at developing new therapies and enhancing treatment protocols, with a focus on translational research that bridges the gap between laboratory discoveries and patient care. Its multidisciplinary approach and dedication to high ethical standards position it as a key player in the landscape of clinical research and healthcare improvement in Italy and beyond.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0